| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Rodney Zeitler | Q68172718 |
| P2093 | author name string | P Fitzpatrick | |
| N W Shammas | |||
| P2860 | cites work | Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase | Q33447121 |
| Patency of the infarct-related coronary artery and ventricular geometry | Q37116950 | ||
| Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction | Q37321328 | ||
| Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy | Q37768664 | ||
| Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies | Q37935371 | ||
| Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommitte | Q37942611 | ||
| Selection of patients with acute myocardial infarction for thrombolytic therapy | Q37992664 | ||
| Comparison of thrombolytic agents: selected hematologic, vascular and clinical events | Q38655936 | ||
| Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction | Q39469964 | ||
| Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction | Q39541800 | ||
| Thrombolytic therapy: current status (1). | Q39640542 | ||
| Insights into the pathogenesis of acute ischemic syndromes | Q39641703 | ||
| Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction | Q41423516 | ||
| GISSI-2 and the heparin controversy | Q42051404 | ||
| Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase | Q42086134 | ||
| Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial | Q44352898 | ||
| Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction | Q45083112 | ||
| Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function | Q47173605 | ||
| A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days | Q47207740 | ||
| Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study | Q47425535 | ||
| Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators. | Q65000815 | ||
| Streptokinase in acute myocardial infarction. European Cooperative Study Group for Streptokinase Treatment in Acute Myocardial Infarction | Q66930494 | ||
| Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) | Q68079937 | ||
| Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction | Q68127838 | ||
| A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators | Q68364308 | ||
| Influence of anterograde flow in the infarct artery on the incidence of late potentials after acute myocardial infarction | Q68720925 | ||
| Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy | Q68727445 | ||
| Heparin and infarct coronary artery patency after streptokinase in acute myocardial infarction | Q68757014 | ||
| Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study | Q68878488 | ||
| A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction | Q69175486 | ||
| Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction | Q69183950 | ||
| Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial | Q69367792 | ||
| Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow | Q69646218 | ||
| Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator | Q69859494 | ||
| Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction | Q69905443 | ||
| Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials | Q69908517 | ||
| Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS) | Q70196897 | ||
| The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial | Q70331348 | ||
| Lessons from the European Cooperative recombinant tissue-type plasminogen activator (rt-PA) versus placebo trial | Q70411841 | ||
| Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction | Q70507873 | ||
| Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials | Q71441157 | ||
| P433 | issue | 4 | |
| P921 | main subject | thrombolysis | Q1931577 |
| P304 | page(s) | 283-292 | |
| P577 | publication date | 1993-04-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Intravenous thrombolytic therapy in myocardial infarction: an analytical review | |
| P478 | volume | 16 |
| Q73171082 | Successful treatment of acute myocardial infarction during pregnancy with tissue plasminogen activator | cites work | P2860 |
Search more.